This Article Full Text Full Text (PDF) Data Supplement Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rosenberg, J. B. Articles by Montgomery, R. R. Search for Related Content PubMed PubMed Citation Articles by Rosenberg, J. B. Articles by Montgomery, R. R. Related Collections Cell biology/structural biology Gene regulation Physiological and pathological control of gene expression Coagulation Gene therapy Endothelium/vascular type/nitric oxide

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:2689.)
© 2000 American Heart Association, Inc.

Thrombosis

Genetic Induction of a Releasable Pool of Factor VIII in Human Endothelial Cells

Jonathan B. Rosenberg; Judith S. Greengard; Robert R. Montgomery

From the Blood Research Institute (J.B.R., R.R.M.), The Blood Center of Southeastern Wisconsin, Milwaukee, Wisc; Department of Pediatrics (R.R.M.), Medical College of Wisconsin, Milwaukee, Wisc; Children’s Hospital of Wisconsin (R.R.M.), Milwaukee, Wisc; and Chiron Corporation (J.S.G.), Emeryville, Calif.

Correspondence to Robert R. Montgomery, MD, Department of Pediatrics, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226. E-mail bob{at}bcsew.edu

Abstract—Although it is known that factor VIII (FVIII) plasma levels increase rapidly in response to a number of stimuli, the biological stimuli behind this release is less clear. Previously, we showed that FVIII can traffic together with von Willebrand factor (vWF) into storage granules in a pituitary tumor cell line, AtT-20; however, AtT-20 cells could not be used to address the release or functional activity of released FVIII. To investigate the regulated secretion of stored FVIII, endothelial cells with intact agonist-stimulated release pathways were used. Human umbilical vein endothelial cells (HUVECs) were transduced with retroviral FVIII construct [hFVIII(V)] to create a FVIII/vWF storage pool. Immunofluorescent staining of transduced cells demonstrated FVIII in Weibel-Palade bodies. In contrast, the transduction of hFVIII(V) into HT-1080 and HepG2 cells displayed FVIII only in the cytoplasm. We studied the regulated release of both FVIII and vWF from endothelial cells after agonist-induced stimulation and demonstrated a parallel release of FVIII and vWF proteins. This released FVIII was functionally active. Hence, endothelial cells transduced with hFVIII(V) store FVIII together with vWF in Weibel-Palade bodies , creating a releasable storage pool of both proteins. Because FVIII secretion can be physiologically regulated by agonists in culture, this may explain the pharmacological agonist-induced release of FVIII by drugs such as desmopressin in vivo and suggests vascular endothelium as a reasonable target of gene therapy of hemophilia A.

Key Words: factor VIII • von Willebrand factor • endothelial cells • agonist stimulation • hemostasis

This article has been cited by other articles:

				O. B. Ekmekci, G. Ozturk, H. Ekmekci, D. Atay, M. Yanasik, S. Anak, and O. Devecioglu Effects of rhG-CSF Plus Dexamethasone on Hemostatic Parameters in Healthy Granulocyte Donors: Role of u-PA and Nitric Oxide Clinical and Applied Thrombosis/Hemostasis, December 1, 2009; 15(6): 689 - 694. [Abstract] [PDF]

				M. van den Biggelaar, E. A.M. Bouwens, N. A. Kootstra, R. P. Hebbel, J. Voorberg, and K. Mertens Storage and regulated secretion of factor VIII in blood outgrowth endothelial cells Haematologica, May 1, 2009; 94(5): 670 - 678. [Abstract] [Full Text] [PDF]

				S. L. Haberichter VWF and FVIII: the origins of a great friendship Blood, March 26, 2009; 113(13): 2873 - 2874. [Full Text] [PDF]

				M. van den Biggelaar, A. B. Meijer, J. Voorberg, and K. Mertens Intracellular cotrafficking of factor VIII and von Willebrand factor type 2N variants to storage organelles Blood, March 26, 2009; 113(13): 3102 - 3109. [Abstract] [Full Text] [PDF]

				M. Jacquemin, A. Neyrinck, M. I. Hermanns, R. Lavend'homme, F. Rega, J.-M. Saint-Remy, K. Peerlinck, D. Van Raemdonck, and C. J. Kirkpatrick FVIII production by human lung microvascular endothelial cells Blood, July 15, 2006; 108(2): 515 - 517. [Abstract] [Full Text] [PDF]

				S. F. De Meyer, K. Vanhoorelbeke, M. K. Chuah, I. Pareyn, V. Gillijns, R. P. Hebbel, D. Collen, H. Deckmyn, and T. VandenDriessche Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor Blood, June 15, 2006; 107(12): 4728 - 4736. [Abstract] [Full Text] [PDF]

				L. Xu, T. C. Nichols, R. Sarkar, S. McCorquodale, D. A. Bellinger, and K. P. Ponder Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy PNAS, April 26, 2005; 102(17): 6080 - 6085. [Abstract] [Full Text] [PDF]

				S. L. Haberichter, E. P. Merricks, S. A. Fahs, P. A. Christopherson, T. C. Nichols, and R. R. Montgomery Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells Blood, January 1, 2005; 105(1): 145 - 152. [Abstract] [Full Text] [PDF]

				S. L. Haberichter, P. Jacobi, and R. R. Montgomery Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storage Blood, February 15, 2003; 101(4): 1384 - 1391. [Abstract] [Full Text] [PDF]

				J. B. Rosenberg, S. L. Haberichter, M. A. Jozwiak, E. A. Vokac, P. A. Kroner, S. A. Fahs, Y. Kawai, and R. R. Montgomery The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF Blood, August 13, 2002; 100(5): 1699 - 1706. [Abstract] [Full Text] [PDF]